Increased prevalence of fatty liver in arterial hypertensive patients – (07-16-04)



Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

See–I’m really NOT making this insulin resistance stuff up!! You would think so because it’s still ignored. Let me put it this way–in my opinion, there is no other condition that even comes close to causing the widespread damage to the human body and increases risk of death and morbidity like insulin resistance. There is no other disease with a prevalence as high as insulin resistance that is so grossly ignored. The medical literature is loaded with info and research on insulin resistance. The condition is very, very amenable to lifestyle changes.

As a summary, if the CDC, the American Diabetic Association, the American Cancer Society and the American Heart Association wanted to have the most dramatic effect on their respective diseases that they have every seen, they would make a huge marketing push to educate the general population on this condition.

Gut — Abstracts: Donati et al. 53 (7): 1020 –

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Fatty Liver, Insulin
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”